All lobbying filings

MICHAEL BEST STRATEGIES LLC

MICHAEL BEST STRATEGIES LLC filed a Q2 report for SAREPTA THERAPEUTICS on July 21, 2025, reporting $40,000 in lobbying income.

Lobbying for SAREPTA THERAPEUTICS · Medical research and drug development company

All filings by MICHAEL BEST STRATEGIES LLC · Everything SAREPTA THERAPEUTICS has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$40,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Rare disease therapeutic development and access

Medical/Disease Research/Clinical Labs

Rare disease therapeutic development and access

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.